6505-01-690-4043
Find complete technical information, availability, and procurement data for: 6505-01-690-4043
DODParts.com distributes related products varnishes dopes paints, aircraft parts and consumables, electrical parts, fittings and other components for the aerospace and defense industries. Submit the short price quote form for NSN 6505-01-690-4043 to receive an up to date pricing and availability quote by email.
A panel, upon which are mounted such items as indicator lights, meters, relays, switches and the like, which is specifically designed for the purpose of controlling the operation of electrical and electronic equipment. See also panel, test, electrical.
infliximab for injection, 100mg per vial part name assigned by controlling agency, intravenous infusion administration, 10.0 milliliters after reconstitution primary container content quantity, vial primary container type, inlflectra is a tissue necrosis factor (tnf) blocker indicated for crohn's disease to reduce the signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy; the lyophilized formulation needs to be reconstituted with 10 ml of sterile water prior to use; packaged as 100 mg; intended for intravenous infusion only; single-use vial; discard unused portion; concentration of final solution 10mg/1ml; must be refrigerated at 2 c to 8 c (36 f to 46 f); do not use inflectra beyond the expiration date; this product contains no preservative. special features
Product Characteristics
Below you’ll find the complete technical specifications and performance data for this part, including material details and compliance information.
- Primary Container Type
- vial
- Primary Container Content Quantity
- 10.0 milliliters after reconstitution
- Administration
- intravenous infusion
- Part Name Assigned By Controlling Agency
- infliximab for injection, 100mg per vial
- Special Features
- inlflectra is a tissue necrosis factor (tnf) blocker indicated for crohn's disease to reduce the signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy; the lyophilized formulation needs to be reconstituted with 10 ml of sterile water prior to use; packaged as 100 mg; intended for intravenous infusion only; single-use vial; discard unused portion; concentration of final solution 10mg/1ml; must be refrigerated at 2 c to 8 c (36 f to 46 f); do not use inflectra beyond the expiration date; this product contains no preservative.
Related Parts
This NSN group includes multiple components designed to meet specific performance and operational standards. Each listing provides detailed specs, functionality data, and replacement compatibility information:
| Part Number | Name |
|---|---|
| 1580055 | Infliximab for Injection |
| 6505NCM206405 | Infliximab for Injection |
| INFLECTRA | Infliximab for Injection |
| NDC00069-0809-01 | Infliximab for Injection |
FAQs
Find helpful answers about installation, operation, maintenance, compliance, and troubleshooting.
What is the FSCG of the NSN 6505-01-690-4043?
Does NSN 6505-01-690-4043 require demilitarization?
Does NSN 6505-01-690-4043 contain precious materials?
Does NSN 6505-01-690-4043 contain hazardous materials?
When the NSN 6505-01-690-4043 was assigned to the Federal Catalog?
Professional Distribution
Certified to meet the strict requirements of defense, aerospace, and hazardous materials distribution.
- ITAR Registered
- DDTC Registered
- HAZMAT Certified
- AS9120 Quality Standards
- 100% Quality Inspections
You May Also Like
Browse other in-demand NSN parts sourced by professionals in defense, aerospace, and manufacturing sectors. Each component meets strict standards for quality and performance.
Pricing
Submit your request below and our team will respond quickly with up-to-date pricing, delivery estimates, and stock information: